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EXTENDED REPORT
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Aims: Mutations of seven crystallin genes have been shown to cause familial cataract. The authors aimed
to identify disease causing crystallin mutations in paediatric cataract families from south eastern Australia.
Methods: 38 families with autosomal dominant or recessive paediatric cataract were examined. Three
large families were studied by linkage analysis. Candidate genes at regions providing significant LOD
scores were sequenced. Single stranded conformational polymorphism (SSCP) analysis was used to screen
five crystallin genes in the probands, followed by direct sequencing of observed electrophoretic shifts.
Mutations predicted to affect the coding sequence were subsequently investigated in the entire pedigree.
Results: A LOD score of 3.72 was obtained at the c-crystallin locus in one pedigree. Sequencing revealed
a P23T mutation of CRYGD, found to segregate with disease. A splice site mutation at the first base of
intron 3 of the CRYBA1/A3 gene segregating with disease was identified by SSCP in another large family.
Five polymorphisms were also detected.
Conclusions: Although mutations in the five crystallin genes comprehensively screened in this study
account for 38% of paediatric cataract mutations in the literature, only two causative mutations were
detected in 38 pedigrees, suggesting that crystallin mutations are a relatively rare cause of the cataract
phenotype in this population.
C
ongenital or paediatric cataract is a clinically and
genetically heterogeneous disorder. The phenotype
varies considerably between and within families.1
Familial paediatric cataract is most commonly inherited in
an autosomal dominant manner, although recessive and X
linked forms also exist.2 Mutations in 14 genes have been
described in association with the phenotype of isolated
paediatric/congenital cataract. These include members of the
crystallin and connexin families,3 membrane proteins MIP4
and LIM2,5 a cytoskeletal protein BFSP2,6 7 and transcription
factors PITX38 and HSF4.9
Mutations in seven crystallin genes have been shown to
cause monogenic paediatric cataract. These include aA-
crystallin (CRYAA),10 11 bA1/A3-crystallin (CRYBA1/A3).12 13
bB2-crystallin (CRYBB2),14 15 cC-crystallin (CRYGC),16 17 and
cD-crystallin (CRYGD).16 18 aB-(CRYAB) and bB1-crystallin
(CRYBB1) mutations19 20 were reported in familial cataract
after the commencement of this study.
While it is apparent that familial cataract is genetically
heterogeneous, only 17 families with crystallin mutations
have been described. It is unknown whether mutations of
these genes are a significant cause of familial cataract. In
order to detect causative mutations in our population of 38
familial paediatric cataract pedigrees from south eastern
Australia, large pedigrees were assessed by linkage analysis,
while the first five reported crystallin genes were screened in
smaller pedigrees by single stranded conformational poly-
morphism (SSCP) analysis.
MATERIALS AND METHODS
Paediatric cataract families and genetic material
Approval was obtained from the human research ethics
committees of the Royal Children’s Hospital, Melbourne, the
Royal Victorian Eye and Ear Hospital, Melbourne, and the
University of Tasmania, Hobart, and informed consent was
obtained from all participants or their guardians.
Ascertainment and recruitment of pedigrees has been
previously described.21 All available family members were
examined by one or more ophthalmologists (MGW, DAM,
JEE, IMR-E, or JEC). Buccal mucosa swabs were collected
and DNA extracted using the PureGene DNA Isolation Kit
(Gentra Systems).
Primer extension preamplification
Primer extension preamplification (PEP)22 was used to
provide sufficient DNA from buccal mucosa swabs for
subsequent polymerase chain reaction (PCR) based amplifi-
cations. Each 50 ml reaction contained 50–100 ng template
DNA, 1000 pmol random PolyN 15-mer primer (Operon
Technologies), 200 mM dNTPs (Promega), 2 mM Mg2+, and
5U Taq Polymerase (Qiagen). The reactions were amplified
over 50 cycles of 92 C˚ for 1 minute, 37 C˚ for 2 minutes, and
55 C˚ for 4 minutes with a final extension of 72 C˚ for
10 minutes, and then diluted to 25–50 ng/ml for PCR.
Linkage analysis
Individuals from three large families were genotyped using
fluorescently labelled primers to amplify microsatellite
markers (table 1) from each of the five crystallin loci and
analysed using an ABI Prism 310 Genetic Analyzer (Applied
Biosystems). Primer sequences and PCR conditions are
available from the Genome Database (www.gdb.org).
Allele frequencies were calculated from founders in the
pedigrees. Two point linkage analysis was carried out with
MLINK, part of the FASTLINK package.23 Disease gene
frequency was set to 0.0001. Penetrance was set at 0.0 in
wild type homozygotes and 0.95 in heterozygotes and mutant
homozygotes. LOD scores were calculated over a range of
recombination distances between 0 and 0.5 for each marker.
Single stranded conformational polymorphism (SSCP)
analysis
The proband from each pedigree, including those investigated
by linkage, was screened for mutations in CRYAA, CRYBA1/A3,
CRYBB2, CRYGC, and CRYGD by SSCP. CRYAB and CRYBB1
had not been associated with cataract at the time of this
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study and were not screened in this way. Both forward and
reverse PCR primers (sequences available on request) were
end labelled with c32P-ATP by T4 polynucleotide kinase (New
England Biolabs). Each exon was amplified by PCR in 10 ml
reaction volumes containing 0.7 mM of each unlabelled
primer and 0.11 mM of each labelled primer, 200 mM dNTPs
(Promega), 0.5 U Taq polymerase (Qiagen), and 50 ng of
DNA. PCR products were mixed with SSCP Stop Solution
(95% formamide, 10 mM NaOH, 0.25% bromophenol blue,
0.25% Xylene Cyanol, all reagents from Sigma-Aldrich),
denatured at 95 C˚ for 2 minutes, and snap cooled on ice.
Samples were electrophoresed on 0.4 mm, 0.5X Mutation
Detection Enhancement (MDE) Gel (Edwards Instrument
Co) at 8 W for 16 hours at room temperature. Products were
visualised on Biomax MR film (Kodak).
DNA sequence analysis
PCR products were cycle sequenced using Big Dye Terminator
Ready Reaction Mix (Applied Biosystems) and an ABI Prism
310 Genetic Analyzer (Applied Biosystems).
Denaturing high performance liquid chromatography
(dHPLC)
Exon 2 of CRYGD was amplified by PCR and injected onto a
Varian Helix dHPLC column at 64 C˚. The acetonitrile
concentration was varied from 45% to 68% over 7 minutes.
Chromatograms were compared to those generated by
samples of known sequence.
Restriction digest
Exon 3 of CRYBA1/A3 was amplified by PCR in pedigree
crch08; 10 ml of PCR product were digested with 1 U of NlaIII
(New England Biolabs) at 37 C˚ for 1 hour. Products were
electrophoresed on a 2% agarose gel and stained with
ethidium bromide.
RESULTS
Thirty eight pedigrees were investigated including 32 with
autosomal dominant inheritance, two autosomal recessive
pedigrees, and four small families of uncertain inheritance.
Linkage analysis of large pedigrees
Four large pedigrees were selected for linkage analysis on the
basis of simulations using SLINK24 25 (data not shown). A
crystallin mutation was detected in pedigree crch08 before
the linkage study, hence this family was not included in
linkage analysis.
LOD scores for the five loci genotyped in the three
remaining large pedigrees are presented in table 1. A
significant LOD score of 3.72 was obtained at h= 0 from
D2S2358 in pedigree ctas17. The two genes at this locus,
CRYGC and CRYGD, were sequenced in three affected and one
unaffected individuals from pedigree ctas17 (see fig 1). Two
variants were detected in exon 2 of CRYGD and screened by
dHPLC in the entire pedigree, 100 normal control chromo-
somes and the proband from each of the other congenital
cataract pedigrees. The first mutation was a synonymous
CRT substitution at the third base of codon 16 (Y16) which
did not segregate with disease and was present in 25% of the
control chromosomes. The second was a non-synonymous
CRA transversion at the first base of codon 24 (P23T). This
mutation segregated with disease in pedigree ctas17 and was
not identified in the control chromosomes or any other
proband.
The phenotype in ctas17 was well documented in only a
few individuals as the majority of patients had surgery before
3 years of age and no clinical photographs were available. The
opacity was a flaky, silica-like nuclear cataract, associated
with a poor red reflex. Best corrected visual acuities after
surgery varied from 6/6 to no perception of light. Thirteen of
the 20 patients with documented visual acuities had at least
6/15 vision in one eye, and two family members met the
criteria for legal blindness (,6/60). Nystagmus was rare.
SSCP analysis
Analysis of the proband from each pedigree revealed one
causative mutation and four non-segregating polymorphisms
(table 2). All mutations identified through SSCP of PEP DNA
were subsequently confirmed by direct sequencing of
genomic DNA, indicating that the use of PEP DNA did not
introduce spurious SSCP positive PCR artefacts.
The GRA transition detected at the first base of the 59
donor splice site of intron 3 in the CRYBA1/A3 gene segregated
with disease in pedigree crch08, as demonstrated by RFLP
analysis (fig 2A). The clinical features of the phakic patients
in this Australian family of European origin showed a
consistent spectrum of: (1) Y-sutural opacities, (2) mild
opacification throughout the region of the fetal nucleus, and
(3) peripheral cortical dot opacities (fig 2B). The severity of
the disease ranged from requiring surgery in childhood to
unawareness of affected status before this study. Individual
III:3 of pedigree crch08 is heterozygous for the mutation.
Mild opacities consistent with his age (65 years) charac-
terised as nuclear sclerosis with cortical opacities were noted
following genotyping revealing his carrier status and could
represent a mild form of the inherited phenotype. As this
mutation and a second mutation at the same base have been
previously shown to segregate with congenital cataract and
not found in 150 control chromosomes of various ethni-
city,12 13 population controls from south eastern Australia
were not screened. The mutation was not detected in any of
the Australian probands.
Table 1 LOD scores obtained for crystallin loci genotyped in three large cataract pedigrees
Pedigree Gene Marker 0.0 0.1 0.2 0.3 0.4 Max LOD h
Crch30 CRYGC/GD* D2S2358 28.62 23.39 21.78 20.89 20.33 0.00 0.50
CRYAB D11S1347 25.25 21.48 20.84 20.46 20.19 0.00 0.50
CRYBA1 D17S841 0.10 0.08 0.07 0.05 0.02 0.10 0.00
CRYAA D21S1890 20.69 0.30 0.29 0.18 0.06 0.32 0.14
CRYBB1/BB2* D22S926 24.10 21.23 20.64 20.35 20.15 0.00 0.50
Crch32 CRYGC/GD* D2S2358 220.87 23.39 21.64 20.50 20.02 0.04 0.45
CRYAB D11S1347 25.21 0.53 0.65 0.52 0.29 0.66 0.18
CRYBA1 D17S841 27.33 22.00 20.72 20.14 0.06 0.07 0.42
CRYAA D21S1890 26.62 21.38 20.22 0.16 0.17 0.20 0.37
CRYBB1/BB2* D22S926 216.44 27.70 21.11 22.05 20.78 0.00 0.50
Ctas17 CRYGC/GD* D2S2358 2.94 3.61 2.89 1.88 0.80 3.72 0.06
CRYBA1 D17S841 211.27 24.06 22.10 21.03 20.39 0.00 0.50
*Two crystallin genes are represented by one microsatellite marker at these loci.
CRYAB and CRYBB1 were not screened by SSCP as they were not reported in the literature at the time of the investigation.
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DISCUSSION
Mutations of crystallin genes represent 45% of the reported
familial cataract mutations to date. We have screened all
genes by linkage, and the first five crystallin genes reported to
cause cataract by SSCP, and detected two mutations that
segregate with the cataract phenotype—CRYGD P23T and a
CRYBA1/A3 splice site mutation—as well as five other non-
disease causing polymorphisms.
This collection of pedigrees were ascertained through a
comprehensive evaluation of almost all familial cataract in
south eastern Australia, a source population of around five
million, and participation rates were high.21 Only those
families with inherited cataract where none of the family
members required specialist medical care and sporadic cases
later shown to be familial would have been overlooked.21
Both the mutations detected in this study have been
previously reported in other large congenital cataract
pedigrees. The P23T mutation of CRYGD has been associated
with differing phenotypes including lamellar cataract in an
Indian pedigree26 and Cerulean cataract in a Moroccan
family.27 Three other mutations of this gene have also been
associated with cataract.16 26 As the P23T mutation has been
found to segregate with congenital cataract in three
independent studies and has not been detected in 400
control chromosomes,26 27 it is unlikely to represent a rare
polymorphism. It is unclear how the P23T mutation affects
the function of the CRYGD protein. The mutation is located
in the second b sheet of the first Greek key motif of the
protein, a region crucial to the correct folding of the protein.27
This residue is a proline or serine in all species represented in
Genbank, but never a threonine. The backbone of the native
human proline forms a hydrogen bond with Asn49. A
threonine at this position maintains this bond but the polar
side chain also forms a strong bond with Tyr50.27 This appears
to be sufficient to cause disease.
A splice site mutation of CRYBA1/A3 has been associated
with pulverulent phenotypes in families from India12 and
Brazil,13 although the Brazilian pedigree had a GRC
transversion, rather than the GRA transition observed in
the Indian and Australian pedigrees. No other mutations of
this gene have been reported. Although individual III:3 of
crch08 carries the CRYBA1/A3 mutation, it is unclear whether
his mild opacity represents expressivity or reduced pene-
trance in the presence of age related cataract. The mutation is
predicted to result in premature termination of the polypep-
tide12 and would affect both the CRYBA1 and CRYBA3
proteins as both are translated from the same mRNA.28 As
with the CRYGD P23T mutation, the presence of mutations of
the same base of the CRYBA1/A3 gene segregating with
cataract phenotype in three independently investigated
pedigrees, and lack of detectable changes in 150 control
chromosomes, indicates that this mutation is likely to be
causative.
Although the splice site mutation detected in intron 3 of
CRYBB2 would be expected to be a functional change it did
not segregate with disease. It is likely that this mutation is
actually in the CRYBB2 pseudogene which has sequence
identity with the translated gene in the region of exon 3.29
SSCP is predicted to detect approximately 70–90% of
sequence variants, depending on the conformation of the
fragment under investigation. The CRYGD P23T mutation was
not detected by SSCP and it is possible that other causative
mutations were undetected. However, SSCP was deemed an
appropriately rapid and inexpensive method for the initial
screen of 19 exons in these pedigrees.
In Australian pedigrees of European ancestry collected
through a population based approach, we have detected two
causative crystallin mutations, both described pre-
viously.12 13 26 27 Considering the different ethnic origins of
the pedigrees, we speculate that these mutations are likely to
have arisen independently. This is only the third report
describing cataract mutations common to more than one
family, and indicates the critical nature of these residues to
the function of the protein in the lens. Mutations of crystallin
genes account for 17 of 38 congenital cataract mutation
reports in the literature. However the low prevalence of
causative mutations in the crystallin genes investigated in
this study—with mutations detected in only two of 38
pedigrees—indicates that they are not a common cause of
familial cataract in this population.
Figure 1 Pedigree of ctas17,
indicating the presence of the CRYGD
P23T mutation. Shaded symbols
indicate the presence of
ophthalmologist confirmed cataract,
and the proband is indicated by an
arrow. + indicates a heterozygote; 2
indicates wild type; individuals without
a + or 2 symbol were unavailable for
genotyping.
Table 2 Variants of crystallin genes detected in cataract families
Gene Exon/intron Position* Base change
Expected effect on
protein
Segregation with
cataract phenotype
CRYBA1/A3 Intron 3 +1 G/A Splice Site Yes
CRYBA1/A3 Exon 5 Codon 152 C/T None (Gly) No
CRYBA1/A3 Intron 2 +73 T/G None No
CRYBA1/A3 Intron 3 +16 C/T None No
CRYBB2 Intron 3 +1 G/A Splice site No
CRYGD Exon 2 Codon 16 C/T None (Tyr) No
CRYGD Exon 2 Codon 23 C/A Pro/Thr Yes
*Intron position numbers refer to the number of nucleotides past the 39 end of the exon.
This variant is likely to be in the presumed pseudogene CRYBB2–2, rather than CRYBB2.
Investigation of crystallin genes 81
www.bjophthalmol.com
 on 16 May 2007 bjo.bmj.comDownloaded from 
ACKNOWLEDGEMENTS
We wish to thank the families for their participation. Thanks to
Susan Stanwix, Mimiwati Zahari, and Danielle Healy for assistance
in arranging ophthalmic examinations and DNA collection, Andrew
Bell and Michele Brown for technical assistance, and Adrian West for
helpful comments on the manuscript. Jamie Craig is supported in
part by an NHMRC practitioner fellowship. Grant support for this
project was received from the Ophthalmic Research Institute of
Australia, the Jack Brockhoff Foundation, and the Royal Hobart
Hospital Research Foundation. The Menzies Centre for Population
Health Research Genetic Epidemiology Unit received financial
support from Cerylid Biosciences.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . .
K P Burdon, J L Dickinson, M M Sale, Menzies Centre for Population
Health Research, University of Tasmania, Hobart, Australia
M G Wirth, Department of Ophthalmology, University of Zu¨rich,
Switzerland
D A Mackey, J E Craig, Centre for Eye Research Australia, University of
Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
I M Russell-Eggitt, Great Ormond Street Hospital for Children, London,
UK
J E Craig, Department of Ophthalmology, Flinders University, Adelaide,
Australia
J E Elder, Department of Ophthalmology, Royal Children’s Hospital,
Melbourne, Australia
M M Sale, Center for Human Genomics and Department of Internal
Medicine, Wake Forest University School of Medicine, Winston-Salem,
USA
REFERENCES
1 Ionides A, Francis P, Berry V, et al. Clinical and genetic heterogeneity in
autosomal dominant cataract. Br J Ophthalmol 1999;83:802–8.
2 Kramer PL, LaMorticella D, Schilling K, et al. A new locus for autosomal
dominant congenital cataracts maps to chromosome 3. Invest Ophthalmol Vis
Sci 2000;41:36–9.
3 Francis PJ, Berry V, Moore AT, et al. Lens biology: development and human
cataractogenesis. Trends Genet 1999;15:191–6.
4 Berry V, Francis P, Kaushal S, et al. Missense mutations in MIP underlie
autosomal dominant ‘polymorphic’ and lamellar cataracts linked to 12q. Nat
Genet 2000;25:15–17.
5 Pras E, Levy-Nissenbaum E, Bakhan T, et al. A missense mutation in the LIM2
gene is associated with autosomal recessive presenile cataract in an inbred
Iraqi Jewish family. Am J Hum Genet 2002;70:1363–7.
6 Conley YP, Erturk D, Keverline A, et al. A Juvenile-onset, progressive cataract
locus on chromosome 3q21–q22 is associated with a missense mutation in the
beaded filament structural protein-2. Am J Hum Genet 2000;66:1426–31.
7 Jakobs PM, Hess JF, Fitzgerald PG, et al. Autosomal-dominant congenital
cataract associated with a deletion mutation in the human beaded filament
protein gene BFSP2. Am J Hum Genet 2000;66:1432–6.
8 Semina EV, Ferrell RE, Mintz-Hittner HA, et al. A novel homeobox gene PITX3
is mutated in families with autosomal-dominant cataracts and ASMD. Nat
Genet 1998;19:167–70.
Figure 2 (A) Restriction fragment length polymorphism analysis of the mutation at the donor splice site of exon 3 of the CRYBA1/A3 gene in pedigree
crch08. Sizes of fragments in the molecular standard lane are indicated in base pairs (bp). Shaded symbols indicate the presence of ophthalmologist
confirmed cataract, and the proband is indicated by an arrow. Wild type individuals display only the 263 bp band. Individuals heterozygous for the
mutation display the undigested 263 bp band, as well as 172 bp and 91 bp cleavage products, although the latter band is not clear on the gel. (B) (i)
Direct and (ii) retroilluminated pictures of sutural, nuclear, and peripheral cortical opacity typical of an affected patient in this pedigree (III:9). There is
considerable intrapedigree variablility of the relative predominance of each component.
82 Burdon, Wirth, Mackey, et al
www.bjophthalmol.com
 on 16 May 2007 bjo.bmj.comDownloaded from 
9 Bu L, Jin Y, Shi Y, et al. Mutant DNA-binding domain of HSF4 is associated
with autosomal dominant lamellar and Marner cataract. Nat Genet
2002;31:276–8.
10 Litt M, Kramer P, LaMorticella D, et al. Autosomal dominant congenital
cataract associated with a missense mutation in the human alpha crystallin
gene CRYAA. Hum Mol Genet 1998;7:471–4.
11 Pras E, Frydman M, Levy-Nissenbaum E, et al. A nonsense mutation (W9X) in
CRYAA causes autosomal recessive cataract in an inbred Jewish Persian
family. Invest Ophthalmol Vis Sci 2000;41:3511–5.
12 Kannabiran C, Rogan PK, Olmos L, et al. Autosomal dominant zonular
cataract with sutural opacities is associated with a splice mutation in the
betaA3/A1-crystallin gene. Mol Vis 1998;4:21.
13 Bateman JB, Geyer DD, Flodman P, et al. A new betaA1-crystallin splice
junction mutation in autosomal dominant cataract. Invest Ophthalmol Vis Sci
2000;41:3278–85.
14 Litt M, Carrero-Valenzuela R, LaMorticella DM, et al. Autosomal dominant
cerulean cataract is associated with a chain termination mutation in the human
beta-crystallin gene CRYBB2. Hum Mol Genet 1997;6:665–8.
15 Gill D, Klose R, Munier FL, et al. Genetic heterogeneity of the Coppock-like
cataract: a mutation in CRYBB2 on chromosome 22q11.2. Invest Ophthalmol
Vis Sci 2000;41:159–65.
16 Heon E, Priston M, Schorderet DF, et al. The gamma-crystallins and human
cataracts: a puzzle made clearer. Am J Hum Genet 1999;65:1261–7.
17 Ren Z, Li A, Shastry BS, et al. A 5-base insertion in the gammaC-crystallin
gene is associated with autosomal dominant variable zonular pulverulent
cataract. Hum Genet 2000;106:531–7.
18 Stephan DA, Gillanders E, Vanderveen D, et al. Progressive juvenile-onset
punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc
Natl Acad Sci USA 1999;96:1008–12.
19 Berry V, Francis P, Reddy MA, et al. Alpha-B crystallin gene (CRYAB) mutation
causes dominant congenital posterior polar cataract in humans. Am J Hum
Genet 2001;69:1141–5.
20 Mackay DS, Boskovska OB, Knopf HL, et al. A nonsense mutation in CRYBB1
associated with autosomal dominant cataract linked to human chromosome
22q. Am J Hum Genet 2002;71:1216–21.
21 Wirth MG, Russell-Eggitt IM, Craig JE, et al. Aetiology of congenital and
paediatric cataract in an Australian population. Br J Ophthalmol
2002;86:782–6.
22 Zhang L, Cui X, Schmitt K, et al. Whole genome amplification from a
single cell: Implications for genetic analysis. Proc Natl Acad Sci
1992;89:5847–51.
23 Cottingham RW Jr, Idury RM, Schaffer AA. Faster sequential genetic linkage
computations. Am J Hum Genet 1993;53:252–63.
24 Ott J. Computer-simulation methods in human linkage analysis. Proc Natl
Acad Sci USA 1989;86:4175–8.
25 Weeks DE, Ott J, Lathrop GM. SLINK: a general simulation program for
linkage analysis. Am J Hum Genet 1990;47(Suppl):A204.
26 Santhiya ST, Shyam Manohar M, Rawlley D, et al. Novel mutations in the
gamma-crystallin genes cause autosomal dominant congenital cataracts.
J Med Genet 2002;39:352–8.
27 Nandrot E, Slingsby C, Basak A, et al. Gamma-D crystallin gene (CRYGD)
mutation causes autosomal dominant congenital cerulean cataracts. J Med
Genet 2003;40:262–7.
28 Werten PJ, Carver JA, Jaenicke R, et al. The elusive role of the N-terminal
extension of beta A3- and beta A1-crystallin. Protein Eng 1996;9:1021–8.
29 Brakenhoff RH, Aarts HJ, Schuren F, et al. The second human beta B2-
crystallin gene is a pseudogene. Exp Eye Res 1992;54:803–6.
www.bjophthalmol.com
 See which articles have just been accepted for publication and
preview the table of contents for the next issue a month before it is published
Future content
What's in the next issue
Investigation of crystallin genes 83
www.bjophthalmol.com
 on 16 May 2007 bjo.bmj.comDownloaded from 
